Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Return on Assets: 2015-2025

Historic Return on Assets for Viking Therapeutics (VKTX) over the last 11 years, with Sep 2025 value amounting to -0.30%.

  • Viking Therapeutics' Return on Assets fell 20.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.17% for FY2024, which is 15.00% up from last year.
  • Per Viking Therapeutics' latest filing, its Return on Assets stood at -0.30% for Q3 2025, which was down 49.59% from -0.20% recorded in Q2 2025.
  • Viking Therapeutics' Return on Assets' 5-year high stood at -0.10% during Q2 2024, with a 5-year trough of -0.45% in Q1 2023.
  • Over the past 3 years, Viking Therapeutics' median Return on Assets value was -0.20% (recorded in 2025), while the average stood at -0.21%.
  • In the last 5 years, Viking Therapeutics' Return on Assets soared by 31bps in 2024 and then dropped by 20bps in 2025.
  • Quarterly analysis of 5 years shows Viking Therapeutics' Return on Assets stood at -0.25% in 2021, then fell by 16bps to -0.41% in 2022, then grew by 18bps to -0.23% in 2023, then climbed by 11bps to -0.12% in 2024, then dropped by 20bps to -0.30% in 2025.
  • Its Return on Assets was -0.30% in Q3 2025, compared to -0.20% in Q2 2025 and -0.14% in Q1 2025.